News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular News and Features for 2016 Shelley Wood December 29, 2016
News Opinion Editor's Corner Las Noticias y Blogs Más Populares de TCTMD en 2016 Shelley Wood December 29, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2016 Shelley Wood November 30, 2016
News Conference News AHA 2016 My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial Shelley Wood November 28, 2016
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Opinion Editor's Corner TCT 2016 My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway Shelley Wood November 07, 2016
News Opinion Editor's Corner TCT 2016 Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones Shelley Wood November 07, 2016
News Daily News Experience Matters: Patients of High-Volume Operators Have Lower Mortality Rates After Left Main PCI Michael O'Riordan October 18, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2016 Shelley Wood September 30, 2016
News Daily News Amid Sparse Data on Infection After ASD Closure, Experts Urge Focus on Dental Health Yael L. Maxwell September 26, 2016
News Daily News Early-Onset Menopause Linked With Poor Cardiovascular Outcomes Yael L. Maxwell September 15, 2016
News Daily News La Endocarditis Infecciosa Post-TAVR se asocia a Diabetes, Regurgitación Aórtica Residual en un Extenso Registro Yael L. Maxwell September 14, 2016
News Daily News Infective Endocarditis After TAVR Linked to Diabetes, Residual Aortic Regurgitation in Large Registry Yael L. Maxwell September 14, 2016
News Daily News Experimental FAAH Inhibitors Do Not Pose Safety Risk, FDA Concludes Michael O'Riordan August 12, 2016